Flamel Technologies SA (FLML) Soars: Stock Up 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 8:39AM CDT
Flamel Technologies SA was a big mover last session, as its shares rose nearly 7% on the day.
Cardiome Pharma Shares Down 10.4% Since SmarTrend's Sell Call (CRME)
Comtex SmarTrend(R) - Wed Apr 16, 9:18AM CDT
SmarTrend identified a Downtrend for Cardiome Pharma (NASDAQ:CRME) on March 31st, 2014 at $7.99. In approximately 2 weeks, Cardiome Pharma has returned 10.39% as of today's recent price of $7.16.
PharmAthene (PIP) Crumbles: Stock Falls by 7.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 7:51AM CDT
PharmAthene saw a big move last session, as the company’s shares fell by over 7% on the day
Flamel Technologies (FLML) Jumps: Stock Adds 9.8% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 7:51AM CDT
Flamel Technologies SA was a big mover last session, as its shares rose nearly 10% on the day.
Catalyst Pharmaceutical Partners Inc. (CPRX) Jumps: Stock Up 8.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 04, 7:51AM CDT
Catalyst Pharmaceutical Partners Inc. was a big mover last session, as its shares rose nearly 9% on the day.
Cardiome Pharma Has Returned 41.3% Since SmarTrend Recommendation (CRME)
Comtex SmarTrend(R) - Mon Mar 31, 4:47PM CDT
SmarTrend identified an Uptrend for Cardiome Pharma (NASDAQ:CRME) on November 21st, 2013 at $5.60. In approximately 4 months, Cardiome Pharma has returned 41.25% as of today's recent price of $7.91.
Cardiome to commercialise BRINAVESS in Greece through Vianex
M2 - Mon Mar 31, 6:10AM CDT
Canadian specialist pharmaceutical company Cardiome Pharma (NASDAQ:CRME)(TSX:COM) revealed on Friday the launch of a commercialisation and distribution of BRINAVESS (vernakalant IV) in Greece.
Cardiome Enters Agreement with VIANEX S.A. to Commercialize BRINAVESS in Greece
PR Newswire Europe - Fri Mar 28, 6:31AM CDT
VANCOUVER, British Columbia, March 28, 2014 /PRNewswire/ --
Cardiome Enters Agreement With Vianex S.A. To Commercialize BRINAVESS In Greece
CNW Group - Fri Mar 28, 6:30AM CDT
NASDAQ: CRME TSX: COM
Cardiome Reports Fourth Quarter and Full Year 2013 Financial Results
CNW Group - Thu Mar 27, 6:00AM CDT
Cardiome to conduct conference call and webcast today, March 27, at 8:00 a.m. Eastern (5:00 a.m. Pacific)
45.7% Return Seen to Date on SmarTrend Cardiome Pharma Call (CRME)
Comtex SmarTrend(R) - Mon Mar 24, 11:00AM CDT
SmarTrend identified an Uptrend for Cardiome Pharma (NASDAQ:CRME) on November 21st, 2013 at $5.60. In approximately 4 months, Cardiome Pharma has returned 45.72% as of today's recent price of $8.16.
Endocyte (ECYT) Soars: Stock Adds 94.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 24, 7:51AM CDT
Endocyte, Inc. was a big mover last session, as its shares rose over 94% on the day.
IntelliPharmaCeutics International (IPCI) Soars: Stock Rises 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 7:51AM CDT
IntelliPharmaCeutics International Inc. was a big mover last session, as its shares rose over 9% on the day.
Cardiome to distribute BRINAVESS in Spain through Logista Pharma SA
M2 - Thu Mar 20, 10:54AM CDT
Pharmaceutical company Cardiome Pharma (NASDAQ:CRME)(TSX:COM) disclosed on Wednesday that it has entered into an agreement for the distribution of BRINAVESS within the Spanish market, for an undisclosed value.
Cardiome To Hold Fourth Quarter And Full Year 2013 Financial Results Conference Call On March 27
CNW Group - Thu Mar 20, 6:45AM CDT
NASDAQ: CRME TSX: COM
ChemoCentryx (CCXI) Jumps: Stock Rises 9.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 19, 7:51AM CDT
ChemoCentryx, Inc. was a big mover last session, as its shares rose nearly 10% on the day.
Cardiome Enters Into an Agreement to Distribute BRINAVESS in Spain
PR Newswire Europe - Wed Mar 19, 6:46AM CDT
VANCOUVER, British Columbia, March 19, 2014 /PRNewswire/ --